Skip to content

Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique

Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02952976
Enrollment
94
Registered
2016-11-02
Start date
2017-07-01
Completion date
2019-12-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Compartment Syndrome, Abdominal Sepsis, Abdominal Trauma

Keywords

open abdomen, Damage control, Abdominal Compartment Syndrome

Brief summary

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases like yours. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera).

Detailed description

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases of open abdomen. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera). The BVPT will be made up by an internal plastic layer to cover abdominal viscera, a second layer with surgical sponges and a suction drain and will be covered by an adhesive plastic layer. Then the dressing will be connected to the hospital's vacuum system. The ABThera dressing is available commercially. Study Participants Enrollment will happen at the operating room Investigator will include in this study patients who have the following indications to laparostomy: * Damage control surgery in trauma patients, * Patients with abdominal compartment syndrome, * Septic shock patients requiring short surgery and inability to close the abdominal cavity. Signing the consent form will be held in order of preference by: 1. Patient 2. Legal representative 3. Doctor appointed by the hospital that does not participate in the study(only in cases where the urgency of the surgery do not allow contact with the representatives). In the latter case the signature of the term should be applied to the legal representative as soon as possible. Criteria for inclusion and exclusion: Inclusion: • Patients with indication of an open abdomen According to the Attending physician (above criteria) Exclusion: * Pregnancy; * Chronic renal impairment, * Child-Pugh C, * Body index over 40 kg / m2, * Uncontrolled bleeding during laparotomy * Patients progressing to death within the first 48 hours Allocation Concealment and Randomization Randomization will be performed by central online dedicated site in the ratio of 1: 1. When a patient is eligible, a surgeon will access the Web site, enter patient's information to know the assigned allocation. Variable block size randomization will be utilized stratified by study center Assuming a closure rate of 75% in the Abthera arm and 35% in the Control arm, a study with 36 patients in each treatment arm (72 total) would have 90% power to detect such a difference at the 0.05 significance level. In order to evaluate closure for 36 patients in each arm, with an estimated loss of 30% either by withdraw or death prior to 48h. So the study will enroll 94 patients (47 in each treatment group) After surgery, patients will be referred to the intensive care unit (ICU). In patients' Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer. In ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX). Primary Objective : • Fascial closure in 30 days Secondary objectives * Demographic variables (gender, age, comorbidities, mechanism of injury or disease), * Indication of laparostomy, * Systolic blood pressure, * Amount of fluid drained by the healing of laparostomy, * Amount of crystalloid, * Amount of hemoconcentrated, * APACHE II ICU admission, * Length of stay in the ICU, * Length of mechanical ventilation, * Length of hospital stay, * Time to closure * Adverse Events * Complications * Mortality. In trauma patients the score Revised Trauma (RTS) and the Injury Severity Score (ISS) will be calculated Statistical analysis Descriptive variables will be summarized as frequencies and percentages. Continuous variable data will be presented as means and standard deviations or medians and ranges, depending on the distribution. The analysis of the qualitative variables will be done through measures of association (chi-square or Fisher 's exact test). The analysis of quantitative variables will be made by means of different tests (parametric and nonparametric) depending on the outcome of the applied normality test

Interventions

DEVICEAbthera

ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX).

DEVICEBarker

In Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer.

Sponsors

Sociedade Brasileira de Atendimento Integrado ao Trauma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with indication of an open abdomen According to the Attending physician * Damage control surgery in trauma patients, * Patients with abdominal compartment syndrome, * Septic shock patients requiring short surgery and inability to close the abdominal cavity.

Exclusion criteria

* Pregnancy; * Chronic renal impairment, * Child-Pugh C, * Body index over 40 kg / m2, * Uncontrolled bleeding during laparotomy * Patients progressing to death within the first 48 hours

Design outcomes

Primary

MeasureTime frameDescription
30 day fascial closure30 dayPercentage of facial closure in each arm

Secondary

MeasureTime frameDescription
Mortality30 daysPercentage of mortality closure in each arm
Drainage30 daysAmount of fluid in ml drained by the dressing

Contacts

Primary ContactDiogo Garcia, MD PhD FACS
diogogarcia@me.com+5511996131077

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026